美国接受抗逆转录病毒治疗的HIV孕妇慢性合并症与产科并发症特征
本研究比较美国两个独立孕妇队列:HIV感染且接受抗逆转录病毒治疗(ART)者(2002-2013年)与无HIV感染者(2002-2007年)。HIV孕妇发生≥2种慢性合并症的比例更高(10% vs 3%;调整OR 2.96;95%CI 2.58-3.41),产科并发症略低(均为17%;
要点
- HIV感染孕妇接受ART者≥2种慢性合并症风险约为无HIV者的3倍。
- HIV孕妇产科并发症总体略低于无HIV者,但早产<37周风险更高。
- 分娩时可检测病毒载量(≥400 copies/mL)与产科并发症风险升高相关。
核心结论
- 接受ART的HIV感染孕妇较无HIV孕妇有更多慢性合并症,但产科并发症不一定更多。
研究设计与样本
- 比较两个独立同期美国孕妇队列:HIV感染且接受ART者来自IMPAACT P1025方案(2002-2013年),无HIV者来自Consortium for Safe Labor研究(2002-2007年)。
- 评估结局为≥2种慢性合并症和产科并发症;HIV孕妇中评估晚产前保健(≥14周)、较早时期开始ART(2002-2008年)和分娩时可检测病毒载量(≥400 copies/mL)与结局的关联。
主要发现
- HIV感染孕妇≥2种慢性合并症比例为10%,无HIV孕妇为3%(调整OR 2.96;95%CI 2.58-3.41)。
- HIV感染孕妇早产<37周的几率更高。
- 晚产前保健和较早时期开始ART与较低≥2种慢性合并症及产科并发症可能性相关;分娩时可检测病毒载量与较高产科并发症可能性相关。
临床怎么用
- 对接受ART的HIV感染孕妇应重视慢性合并症的筛查与管理。
- 关注HIV感染孕妇早产风险,并尽量在分娩前控制病毒载量至检测不到以降低产科并发症风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To evaluate the frequency and associated characteristics of chronic comorbid conditions and obstetrical complications among pregnant women with human immunodeficiency virus (HIV) and receiving antiretroviral therapy (ART) in comparison to those without HIV. METHODS: We compared 2 independent concurrent US pregnancy cohorts: (1) with HIV (International Maternal Pediatric Adolescent AIDS Clinical Trials Protocol P1025, 2002-2013) and (2) without HIV (Consortium for Safe Labor Study, 2002-2007). Outcomes were ≥2 chronic comorbid conditions and obstetrical complications. For women with HIV, we assessed whether late prenatal care (≥14 weeks), starting ART in an earlier era (2002-2008), and a detectable viral load at delivery (≥400 copies/mL) were associated with study outcomes. RESULTS: We assessed 2868 deliveries (n = 2574 women) with HIV and receiving ART and 211 910 deliveries (n = 193 170 women) without HIV. Women with HIV were more likely to have ≥2 chronic comorbid conditions versus those without HIV (10 vs 3%; adjusted OR [AOR]: 2.96; 95% CI: 2.58-3.41). Women with HIV were slightly less likely to have obstetrical complications versus those without HIV (both 17%; AOR: .84; 95% CI: .75-.94), but secondarily, higher odds of preterm birth <37 weeks. Late entry to prenatal care and starting ART in an earlier era were associated with a lower likelihood of ≥2 chronic comorbidities and obstetrical complications; detectable viral load at delivery was associated with a higher likelihood of obstetric complications. CONCLUSIONS: Pregnant women with HIV receiving ART have more chronic comorbid conditions, but not necessarily obstetrical complications, than their peers without HIV.
引用
- Venkatesh KK, Morrison L, Tuomala RE, et al. Profile of Chronic Comorbid Conditions and Obstetrical Complications Among Pregnant Women With Human Immunodeficiency Virus and Receiving Antiretroviral Therapy in the United States. Clin Infect Dis. 2021. PMID: 33768226. doi:10.1093/cid/ciab203
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。